Interleukin-2 Based Home Therapy of Metastatic Renal Cell Carcinoma
- 1 January 1996
- journal article
- Published by Wolters Kluwer Health in Journal of Urology
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- Prognostic factors for survival in patients with advanced renal cell carcinoma treated with recombinant interleukin-2Annals of Oncology, 1992
- Concomitant administration of recombinant human interleukin-2 and recombinant interferon alfa-2A: an active outpatient regimen in metastatic renal cell carcinoma.Journal of Clinical Oncology, 1992
- A dual anti-tumor effect of a combination of interferon-α or interleukin-2 and 5-fluorouracil on natural killer (NK) cell-mediated cytotoxicityClinical Immunology and Immunopathology, 1992
- Home therapy with recombinant interleukin-2 and interferon-$alpha;2b in advanced human malignanciesThe Lancet, 1990
- Prognostic factors of adult metastatic renal carcinoma: A multivariate analysisSeminars in Surgical Oncology, 1988
- A Progress Report on the Treatment of 157 Patients with Advanced Cancer Using Lymphokine-Activated Killer Cells and Interleukin-2 or High-Dose Interleukin-2 AloneNew England Journal of Medicine, 1987
- Constant-Infusion Recombinant Interleukin-2 in Adoptive Immunotherapy of Advanced CancerNew England Journal of Medicine, 1987
- Prognostic Factors in Metastatic Renal CarcinomaJournal of Urology, 1986
- Renal Cell Carcinoma: Natural History and Results of TreatmentJournal of Urology, 1978
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958